CLINICAL_TRIALS
trial_result
· 2007-01-01
Clinical Trial Update: To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy. [Phase 2]
Summary
Pfizer completed a Phase 2 study to evaluate the long-term safety of pregabalin in patients with refractory partial epilepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Epilepsy, Partial | Phase 2 | Status: COMPLETED